_id
691722e93c536f8df23169a4
Ticker
TSHA
Name
Taysha Gene Therapies Inc
Exchange
NASDAQ
Address
3000 Pegasus Park Drive, Dallas, TX, United States, 75247
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.tayshagtx.com
Description
Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Last Close
5.76
Volume
2539446
Current Price
5.79
Change
0.5208333333333376
Last Updated
2025-12-04T14:30:05.366Z
Image
https://logo.clearbit.com/www.tayshagtx.com
Ipo Date
2020-09-24T00:00:00.000Z
Market Cap
1229897856
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9855
Sentiment Sources
2
Rating
4.7
Target Price
10.5385
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
286000
Gross Profit
-286000
Operating Expenses
33738000
Operating Income
-34024000
Interest Expense
15000
Pretax Income
-32732999
Net Income
-32732999
Eps
-0.09264680620384295
Dividends Per Share
-
Shares Outstanding
273919373
Income Tax Expense
-
EBITDA
-32431999
Operating Margin
-
Total Other Income Expense Net
1291000
Cash
297344000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
299951000
Property Plant Equipment
14268000
Total Assets
316554000
Payables
5438000
Short Term Debt
1668000
Long Term Debt
50852000
Total Liabilities
97565000
Equity
218989000
Depreciation
433000
Change In Working Capital
5979000
Cash From Operations
-24166000
Capital Expenditures
108000
Cash From Investing
-48000
Cash From Financing
8797000
Net Change In Cash
-15417000
PE
-
PB
9.341392234130483
ROE
-14.947325664759417
ROA
-10.340415537317488
FCF
-24274000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
286000
Quarters > 0 > income Statement > gross Profit
-286000
Quarters > 0 > income Statement > operating Expenses
33738000
Quarters > 0 > income Statement > operating Income
-34024000
Quarters > 0 > income Statement > interest Expense
15000
Quarters > 0 > income Statement > pretax Income
-32732999
Quarters > 0 > income Statement > net Income
-32732999
Quarters > 0 > income Statement > eps
-0.09264680620384295
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
353309524
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-32431999
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1291000
Quarters > 0 > balance Sheet > cash
297344000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
299951000
Quarters > 0 > balance Sheet > property Plant Equipment
14268000
Quarters > 0 > balance Sheet > total Assets
316554000
Quarters > 0 > balance Sheet > payables
5438000
Quarters > 0 > balance Sheet > short Term Debt
1668000
Quarters > 0 > balance Sheet > long Term Debt
50852000
Quarters > 0 > balance Sheet > total Liabilities
97565000
Quarters > 0 > balance Sheet > equity
218989000
Quarters > 0 > cash Flow > net Income
-32732999
Quarters > 0 > cash Flow > depreciation
433000
Quarters > 0 > cash Flow > change In Working Capital
5979000
Quarters > 0 > cash Flow > cash From Operations
-24166000
Quarters > 0 > cash Flow > capital Expenditures
108000
Quarters > 0 > cash Flow > cash From Investing
-48000
Quarters > 0 > cash Flow > cash From Financing
8797000
Quarters > 0 > cash Flow > net Change In Cash
-15417000
Quarters > 0 > ratios > PE
-0.09264680620384295
Quarters > 0 > ratios > PB
9.341392234130483
Quarters > 0 > ratios > ROE
-14.947325664759417
Quarters > 0 > ratios > ROA
-10.340415537317488
Quarters > 0 > ratios > FCF
-24274000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1986000
Quarters > 1 > income Statement > cost Of Revenue
277000
Quarters > 1 > income Statement > gross Profit
1986000
Quarters > 1 > income Statement > operating Expenses
28739000
Quarters > 1 > income Statement > operating Income
-26753000
Quarters > 1 > income Statement > interest Expense
17000
Quarters > 1 > income Statement > pretax Income
-26882000
Quarters > 1 > income Statement > net Income
-26882000
Quarters > 1 > income Statement > eps
-0.09021139030182519
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
297988978
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-26588000
Quarters > 1 > income Statement > operating Margin
-1347.079556898288
Quarters > 1 > income Statement > total Other Income Expense Net
-129000
Quarters > 1 > balance Sheet > cash
312761000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
316264000
Quarters > 1 > balance Sheet > property Plant Equipment
14730000
Quarters > 1 > balance Sheet > total Assets
333331000
Quarters > 1 > balance Sheet > payables
7713000
Quarters > 1 > balance Sheet > short Term Debt
1738000
Quarters > 1 > balance Sheet > long Term Debt
41051000
Quarters > 1 > balance Sheet > total Liabilities
84604000
Quarters > 1 > balance Sheet > equity
248727000
Quarters > 1 > cash Flow > net Income
-26882000
Quarters > 1 > cash Flow > depreciation
277000
Quarters > 1 > cash Flow > change In Working Capital
2226000
Quarters > 1 > cash Flow > cash From Operations
-20182000
Quarters > 1 > cash Flow > capital Expenditures
2000
Quarters > 1 > cash Flow > cash From Investing
62000
Quarters > 1 > cash Flow > cash From Financing
216288000
Quarters > 1 > cash Flow > net Change In Cash
196168000
Quarters > 1 > ratios > PE
-0.09021139030182519
Quarters > 1 > ratios > PB
6.93674664439325
Quarters > 1 > ratios > ROE
-10.807833488121513
Quarters > 1 > ratios > ROA
-8.064656452595168
Quarters > 1 > ratios > FCF
-20184000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-10.163141993957703
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2302000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2302000
Quarters > 2 > income Statement > operating Expenses
23723000
Quarters > 2 > income Statement > operating Income
-21421000
Quarters > 2 > income Statement > interest Expense
19000
Quarters > 2 > income Statement > pretax Income
-21529000
Quarters > 2 > income Statement > net Income
-21529000
Quarters > 2 > income Statement > eps
-0.07994242066295872
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
269306331
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-21227000
Quarters > 2 > income Statement > operating Margin
-930.5386620330148
Quarters > 2 > income Statement > total Other Income Expense Net
-108000
Quarters > 2 > balance Sheet > cash
116593000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
120708000
Quarters > 2 > balance Sheet > property Plant Equipment
15315000
Quarters > 2 > balance Sheet > total Assets
138362000
Quarters > 2 > balance Sheet > payables
4326000
Quarters > 2 > balance Sheet > short Term Debt
1808000
Quarters > 2 > balance Sheet > long Term Debt
42453000
Quarters > 2 > balance Sheet > total Liabilities
83303000
Quarters > 2 > balance Sheet > equity
55059000
Quarters > 2 > cash Flow > net Income
-21529000
Quarters > 2 > cash Flow > depreciation
283000
Quarters > 2 > cash Flow > change In Working Capital
-4556000
Quarters > 2 > cash Flow > cash From Operations
-22020000
Quarters > 2 > cash Flow > capital Expenditures
378000
Quarters > 2 > cash Flow > cash From Investing
-371000
Quarters > 2 > cash Flow > cash From Financing
-52000
Quarters > 2 > cash Flow > net Change In Cash
-22443000
Quarters > 2 > ratios > PE
-0.07994242066295872
Quarters > 2 > ratios > PB
28.320232050890862
Quarters > 2 > ratios > ROE
-39.10169091338383
Quarters > 2 > ratios > ROA
-15.559908067243896
Quarters > 2 > ratios > FCF
-22398000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-9.729800173761946
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2022000
Quarters > 3 > income Statement > cost Of Revenue
-625000
Quarters > 3 > income Statement > gross Profit
2022000
Quarters > 3 > income Statement > operating Expenses
21954000
Quarters > 3 > income Statement > operating Income
-19932000
Quarters > 3 > income Statement > interest Expense
22000
Quarters > 3 > income Statement > pretax Income
-18785000
Quarters > 3 > income Statement > net Income
-18785000
Quarters > 3 > income Statement > eps
-0.09165949533379734
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
204943306
Quarters > 3 > income Statement > income Tax Expense
-281724
Quarters > 3 > income Statement > EBITDA
-18459000
Quarters > 3 > income Statement > operating Margin
-985.7566765578636
Quarters > 3 > income Statement > total Other Income Expense Net
1147000
Quarters > 3 > balance Sheet > cash
139036000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
142130000
Quarters > 3 > balance Sheet > property Plant Equipment
15866000
Quarters > 3 > balance Sheet > total Assets
160364000
Quarters > 3 > balance Sheet > payables
3592000
Quarters > 3 > balance Sheet > short Term Debt
1877000
Quarters > 3 > balance Sheet > long Term Debt
43942000
Quarters > 3 > balance Sheet > total Liabilities
88839000
Quarters > 3 > balance Sheet > equity
71525000
Quarters > 3 > cash Flow > net Income
-18785000
Quarters > 3 > cash Flow > depreciation
304000
Quarters > 3 > cash Flow > change In Working Capital
-2601000
Quarters > 3 > cash Flow > cash From Operations
-18308000
Quarters > 3 > cash Flow > capital Expenditures
2000
Quarters > 3 > cash Flow > cash From Investing
13000
Quarters > 3 > cash Flow > cash From Financing
-357000
Quarters > 3 > cash Flow > net Change In Cash
-18652000
Quarters > 3 > ratios > PE
-0.09165949533379734
Quarters > 3 > ratios > PB
16.59030746927648
Quarters > 3 > ratios > ROE
-26.26354421530933
Quarters > 3 > ratios > ROA
-11.71397570527051
Quarters > 3 > ratios > FCF
-18310000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.055390702274975
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8333000
Annuals > 0 > income Statement > cost Of Revenue
1245000
Annuals > 0 > income Statement > gross Profit
8333000
Annuals > 0 > income Statement > operating Expenses
99792000
Annuals > 0 > income Statement > operating Income
-91459000
Annuals > 0 > income Statement > interest Expense
102000
Annuals > 0 > income Statement > pretax Income
-89298000
Annuals > 0 > income Statement > net Income
-89298000
Annuals > 0 > income Statement > eps
-0.35700004678684344
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
250134421
Annuals > 0 > income Statement > income Tax Expense
-89298000
Annuals > 0 > income Statement > EBITDA
-87951000
Annuals > 0 > income Statement > operating Margin
-1097.551902076083
Annuals > 0 > income Statement > total Other Income Expense Net
2161000
Annuals > 0 > balance Sheet > cash
139036000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
142130000
Annuals > 0 > balance Sheet > property Plant Equipment
15866000
Annuals > 0 > balance Sheet > total Assets
160364000
Annuals > 0 > balance Sheet > payables
3592000
Annuals > 0 > balance Sheet > short Term Debt
1877000
Annuals > 0 > balance Sheet > long Term Debt
43942000
Annuals > 0 > balance Sheet > total Liabilities
88839000
Annuals > 0 > balance Sheet > equity
71525000
Annuals > 0 > cash Flow > net Income
-89298000
Annuals > 0 > cash Flow > depreciation
1245000
Annuals > 0 > cash Flow > change In Working Capital
-12467000
Annuals > 0 > cash Flow > cash From Operations
-81225000
Annuals > 0 > cash Flow > capital Expenditures
374000
Annuals > 0 > cash Flow > cash From Investing
-363000
Annuals > 0 > cash Flow > cash From Financing
76684000
Annuals > 0 > cash Flow > net Change In Cash
-4904000
Annuals > 0 > ratios > PE
-0.35700004678684344
Annuals > 0 > ratios > PB
15.702251664313177
Annuals > 0 > ratios > ROE
-124.8486543166725
Annuals > 0 > ratios > ROA
-55.68456760869023
Annuals > 0 > ratios > FCF
-81599000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-9.792271690867635
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
15451000
Annuals > 1 > income Statement > cost Of Revenue
1371000
Annuals > 1 > income Statement > gross Profit
15451000
Annuals > 1 > income Statement > operating Expenses
87890000
Annuals > 1 > income Statement > operating Income
-72439000
Annuals > 1 > income Statement > interest Expense
4998000
Annuals > 1 > income Statement > pretax Income
-111566000
Annuals > 1 > income Statement > net Income
-111566000
Annuals > 1 > income Statement > eps
-0.9607696877309919
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
116121482
Annuals > 1 > income Statement > income Tax Expense
1203105
Annuals > 1 > income Statement > EBITDA
-105197000
Annuals > 1 > income Statement > operating Margin
-468.8304964079995
Annuals > 1 > income Statement > total Other Income Expense Net
-39127000
Annuals > 1 > balance Sheet > cash
143940000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
149868000
Annuals > 1 > balance Sheet > property Plant Equipment
20408000
Annuals > 1 > balance Sheet > total Assets
172731000
Annuals > 1 > balance Sheet > payables
6366000
Annuals > 1 > balance Sheet > short Term Debt
1646000
Annuals > 1 > balance Sheet > long Term Debt
40508000
Annuals > 1 > balance Sheet > total Liabilities
97794000
Annuals > 1 > balance Sheet > equity
74937000
Annuals > 1 > cash Flow > net Income
-111566000
Annuals > 1 > cash Flow > depreciation
1371000
Annuals > 1 > cash Flow > change In Working Capital
-18012000
Annuals > 1 > cash Flow > cash From Operations
-73018000
Annuals > 1 > cash Flow > capital Expenditures
7369000
Annuals > 1 > cash Flow > cash From Investing
-7352000
Annuals > 1 > cash Flow > cash From Financing
136393000
Annuals > 1 > cash Flow > net Change In Cash
56023000
Annuals > 1 > ratios > PE
-0.9607696877309919
Annuals > 1 > ratios > PB
6.957650482138329
Annuals > 1 > ratios > ROE
-148.87972563620107
Annuals > 1 > ratios > ROA
-64.58944833295702
Annuals > 1 > ratios > FCF
-80387000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-5.202705326516083
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2502000
Annuals > 2 > income Statement > cost Of Revenue
2487000
Annuals > 2 > income Statement > gross Profit
14999
Annuals > 2 > income Statement > operating Expenses
126042000
Annuals > 2 > income Statement > operating Income
-126027000
Annuals > 2 > income Statement > interest Expense
3798000
Annuals > 2 > income Statement > pretax Income
-166014000
Annuals > 2 > income Statement > net Income
-166014000
Annuals > 2 > income Statement > eps
-3.7771647101958807
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
43952015
Annuals > 2 > income Statement > income Tax Expense
3567000
Annuals > 2 > income Statement > EBITDA
-159729000
Annuals > 2 > income Statement > operating Margin
-5037.05035971223
Annuals > 2 > income Statement > total Other Income Expense Net
-39987000
Annuals > 2 > balance Sheet > cash
87880000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
96417000
Annuals > 2 > balance Sheet > property Plant Equipment
25906000
Annuals > 2 > balance Sheet > total Assets
126276000
Annuals > 2 > balance Sheet > payables
10946000
Annuals > 2 > balance Sheet > short Term Debt
1521000
Annuals > 2 > balance Sheet > long Term Debt
37967000
Annuals > 2 > balance Sheet > total Liabilities
125327000
Annuals > 2 > balance Sheet > equity
949000
Annuals > 2 > cash Flow > net Income
-166014000
Annuals > 2 > cash Flow > depreciation
1172000
Annuals > 2 > cash Flow > change In Working Capital
18518000
Annuals > 2 > cash Flow > cash From Operations
-88390000
Annuals > 2 > cash Flow > capital Expenditures
24869000
Annuals > 2 > cash Flow > cash From Investing
-24930000
Annuals > 2 > cash Flow > cash From Financing
52097000
Annuals > 2 > cash Flow > net Change In Cash
-61223000
Annuals > 2 > ratios > PE
-3.7771647101958807
Annuals > 2 > ratios > PB
207.94999720758696
Annuals > 2 > ratios > ROE
-17493.572181243413
Annuals > 2 > ratios > ROA
-131.46916278627768
Annuals > 2 > ratios > FCF
-113259000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-45.2673860911271
Annuals > 2 > health Score
9
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
492000
Annuals > 3 > income Statement > gross Profit
-492000
Annuals > 3 > income Statement > operating Expenses
173267000
Annuals > 3 > income Statement > operating Income
-173267000
Annuals > 3 > income Statement > interest Expense
1428000
Annuals > 3 > income Statement > pretax Income
-174523000
Annuals > 3 > income Statement > net Income
-174523000
Annuals > 3 > income Statement > eps
-4.635335362554709
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37650566
Annuals > 3 > income Statement > income Tax Expense
936000
Annuals > 3 > income Statement > EBITDA
-172603000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1256000
Annuals > 3 > balance Sheet > cash
149103000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
159602000
Annuals > 3 > balance Sheet > property Plant Equipment
50610000
Annuals > 3 > balance Sheet > total Assets
213956000
Annuals > 3 > balance Sheet > payables
21763000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
37192000
Annuals > 3 > balance Sheet > total Liabilities
118573000
Annuals > 3 > balance Sheet > equity
95383000
Annuals > 3 > cash Flow > net Income
-174523000
Annuals > 3 > cash Flow > depreciation
492000
Annuals > 3 > cash Flow > change In Working Capital
28667000
Annuals > 3 > cash Flow > cash From Operations
-117042000
Annuals > 3 > cash Flow > capital Expenditures
21554000
Annuals > 3 > cash Flow > cash From Investing
-21554000
Annuals > 3 > cash Flow > cash From Financing
39083000
Annuals > 3 > cash Flow > net Change In Cash
-99513000
Annuals > 3 > ratios > PE
-4.635335362554709
Annuals > 3 > ratios > PB
1.7723393197949322
Annuals > 3 > ratios > ROE
-182.97075998867723
Annuals > 3 > ratios > ROA
-81.5695750528146
Annuals > 3 > ratios > FCF
-138596000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
24
Valuation > metrics > PE
-0.09264680620384295
Valuation > metrics > PB
9.341392234130483
Valuation > final Score
20
Valuation > verdict
211.4% Overvalued
Profitability > metrics > ROE
-14.947325664759417
Profitability > metrics > ROA
-10.912782087740998
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4455246610560348
Risk > metrics > Interest Coverage
-2268.266666666667
Risk > final Score
-9013
Risk > verdict
High
Liquidity > metrics > Current Ratio
42.21094849423023
Liquidity > metrics > Quick Ratio
42.21094849423023
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-6235
Prev Risks > 1
-4480
Prev Risks > 2
-3594
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:20:12.413Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0976
Earnings History > 0 > eps Difference
0.0976
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0875
Earnings History > 1 > eps Estimate
-0.08
Earnings History > 1 > eps Difference
-0.0075
Earnings History > 1 > surprise Percent
-9.375
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-12
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.08
Earnings History > 2 > eps Estimate
-0.07
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-14.2857
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-15
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.07
Earnings History > 3 > eps Estimate
-0.09
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
22.2222
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.07
Earnings History > 4 > eps Estimate
-0.08
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
12.5
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.07
Earnings History > 5 > eps Estimate
-0.09
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
22.2222
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-12
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.09
Earnings History > 6 > eps Estimate
-0.16
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
43.75
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1
Earnings History > 7 > eps Estimate
-0.11
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
9.0909
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-19
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.92
Earnings History > 8 > eps Estimate
-0.11
Earnings History > 8 > eps Difference
1.03
Earnings History > 8 > surprise Percent
936.3636
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.13
Earnings History > 9 > eps Estimate
-0.17
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
23.5294
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
-0.31
Earnings History > 10 > eps Difference
-0.07
Earnings History > 10 > surprise Percent
-22.5806
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.28
Earnings History > 11 > eps Estimate
-0.35
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
20
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-28
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.99
Earnings History > 12 > eps Estimate
-0.33
Earnings History > 12 > eps Difference
-0.66
Earnings History > 12 > surprise Percent
-200
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.64
Earnings History > 13 > eps Estimate
-0.82
Earnings History > 13 > eps Difference
0.18
Earnings History > 13 > surprise Percent
21.9512
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.84
Earnings History > 14 > eps Estimate
-1
Earnings History > 14 > eps Difference
0.16
Earnings History > 14 > surprise Percent
16
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.31
Earnings History > 15 > eps Estimate
-1.07
Earnings History > 15 > eps Difference
-0.24
Earnings History > 15 > surprise Percent
-22.4299
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.32
Earnings History > 16 > eps Estimate
-1.25
Earnings History > 16 > eps Difference
-0.07
Earnings History > 16 > surprise Percent
-5.6
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.35
Earnings History > 17 > eps Estimate
-1.08
Earnings History > 17 > eps Difference
-0.27
Earnings History > 17 > surprise Percent
-25
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.09
Earnings History > 18 > eps Estimate
-0.84
Earnings History > 18 > eps Difference
-0.25
Earnings History > 18 > surprise Percent
-29.7619
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.87
Earnings History > 19 > eps Estimate
-0.56
Earnings History > 19 > eps Difference
-0.31
Earnings History > 19 > surprise Percent
-55.3571
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-03
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.04
Earnings History > 20 > eps Estimate
-0.37
Earnings History > 20 > eps Difference
-0.67
Earnings History > 20 > surprise Percent
-181.0811
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.28
Earnings History > 21 > eps Estimate
-0.17
Earnings History > 21 > eps Difference
-1.11
Earnings History > 21 > surprise Percent
-652.9412
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-25
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.28
Earnings History > 22 > eps Estimate
-1.28
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATaysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen - Defense World
12/13/2025
Taysha Gene Therapies (NASDAQ:TSHA) Rating Increased to Hold at Wall Street Zen Defense World
Read more →Taysha Gene Therapies (TSHA) Is Up 13.8% After TSHA-102 Phase 3 Upgrade Momentum - Has The Bull Case Changed? simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$10.5385
Analyst Picks
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 95.37% of the total shares of Taysha Gene Therapies Inc
1.
RTW INVESTMENTS, LLC(9.1723%)
since
2025/06/30
2.
RA Capital Management, LLC(8.6349%)
since
2025/06/30
3.
venBio Select Advisor LLC(7.9547%)
since
2025/06/30
4.
Morgan Stanley - Brokerage Accounts(6.1823%)
since
2025/06/30
5.
FMR Inc(5.7288%)
since
2025/06/30
6.
BlackRock Inc(4.8768%)
since
2025/06/30
7.
Octagon Capital Advisors LP(4.6161%)
since
2025/06/30
8.
Goldman Sachs Group Inc(4.6143%)
since
2025/06/30
9.
Siren, L.L.C.(4.0377%)
since
2025/06/30
10.
Vanguard Group Inc(3.9935%)
since
2025/06/30
11.
Jefferies Financial Group Inc(3.7808%)
since
2025/06/30
12.
Point72 Asset Management, L.P.(2.6825%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(2.4315%)
since
2025/07/31
14.
Deerfield Management Co(1.9744%)
since
2025/06/30
15.
Fidelity Growth Compy Commingled Pl S(1.969%)
since
2025/07/31
16.
State Street Corp(1.8836%)
since
2025/06/30
17.
Polar Capital Holdings PLC(1.8329%)
since
2025/06/30
18.
Polar Capital Biotech S Inc(1.8329%)
since
2025/07/31
19.
Adage Capital Partners Gp LLC(1.7739%)
since
2025/06/30
20.
The Toronto-Dominion Bank(1.7335%)
since
2025/06/30
21.
Fidelity Growth Company Fund(1.5416%)
since
2025/07/31
22.
Tybourne Capital Management (HK) Ltd(1.5011%)
since
2025/06/30
23.
iShares Russell 2000 ETF(1.476%)
since
2025/08/31
24.
Baker Bros Advisors LP(1.468%)
since
2025/06/30
25.
Geode Capital Management, LLC(1.3906%)
since
2025/06/30
26.
Fidelity Select Biotechnology(1.2679%)
since
2025/07/31
27.
Fidelity Small Cap Index(0.6103%)
since
2025/06/30
28.
Vanguard Institutional Extnd Mkt Idx Tr(0.5889%)
since
2025/07/31
29.
Fidelity Growth Company K6(0.5559%)
since
2025/07/31
30.
iShares Russell 2000 Growth ETF(0.5319%)
since
2025/08/31
31.
SPDR® S&P Biotech ETF(0.5301%)
since
2025/08/31
32.
iShares Biotechnology ETF(0.4699%)
since
2025/08/31
33.
Fidelity Series Growth Company(0.3604%)
since
2025/07/31
34.
Fidelity Extended Market Index(0.3005%)
since
2025/07/31
35.
Vanguard Russell 2000 ETF(0.2894%)
since
2025/07/31
36.
State St Russell Sm Cap® Indx SL Cl I(0.2118%)
since
2025/08/31
37.
Schwab Small Cap Index(0.1528%)
since
2025/07/31
38.
NT R2000 Index Fund - NL(0.147%)
since
2025/06/30
39.
iShares Micro-Cap ETF(0.1376%)
since
2025/08/31
40.
Vanguard Health Care ETF(0.1278%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0976
Date
2025-09-30
EPS Actual
-0.0875
EPS Estimate
-0.08
EPS Difference
-0.0075
Surprise Percent
-9.375%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.